Mitochondrial Energy Processes in Huntington’s May Be Normal After All
Feb 02, 2017 09:21 am | Magdalena Kegel
Mitochondrial abnormalities may not contribute to the degeneration of neurons in the striatum in patients with Huntington’s disease, according to a study that provides evidence contradicting several earlier findings. The study explored mitochondrial processes in a mouse model of Huntington’s disease and found that mitochondria from the striatum — the brain region mainly affected in […]
The post Mitochondrial Energy Processes in Huntington’s May Be Normal After All appeared first on Huntington's Disease News. |
Mitochondrial abnormalities may not contribute to the degeneration of neurons in the striatum in patients with Huntington’s disease, according to a study that provides evidence contradicting several earlier findings. The study explored mitochondrial processes in a mouse model of Huntington’s disease and found that mitochondria from the striatum — the brain region mainly affected in […]
A patent application for Vybion’s potential gene therapy for Huntington’s disease (HD) and other neurodegenerative conditions has been granted Track One status by the U.S. Patent and Trademark Office (USPTO). Patent applications are ordinarily reviewed in the order of their filing date, with the process taking about three years. The USPTO’s goal with Track One […]